Evidence map›Paper›PMID 35237054›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2022

The Association of the Prevalence of Depression in Type 2 Diabetes Mellitus with Visual-Related Quality of Life and Social Support.

Xiaoxia Ding, Shisong Rong, Yu Wang, Dong Li, Liang Wen, Bo Zou, Dongxiao Zang, Kemi Feng, Yuanbo Liang, Fenghua Wang and 1 more

Abstract read
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaoxia DingDepartment of Ophthalmology, Fushun Eye Hospital, Fushun, Liaoning, People's Republic of China.ORCID 0000-0002-6712-3043
Shisong RongDepartment of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear, Boston, MA, USA.ORCID 0000-0001-8352-6363
Yu WangDepartment of Ophthalmology, Fushun Eye Hospital, Fushun, Liaoning, People's Republic of China.
Dong LiDepartment of Ophthalmology, Fushun Eye Hospital, Fushun, Liaoning, People's Republic of China.
Liang WenDepartment of Ophthalmology, Fushun Eye Hospital, Fushun, Liaoning, People's Republic of China.
Bo ZouDepartment of Ophthalmology, Fushun Eye Hospital, Fushun, Liaoning, People's Republic of China.
Dongxiao ZangDepartment of Ophthalmology, Fushun Eye Hospital, Fushun, Liaoning, People's Republic of China.
Kemi FengDepartment of Ophthalmology, the Affiliated Eye Hospital, School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Yuanbo LiangDepartment of Ophthalmology, the Affiliated Eye Hospital, School of Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Fenghua WangDepartment of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Science Key Laboratory, Beijing, People's Republic of China.
Gang ZhaiDepartment of Ophthalmology, Fushun Eye Hospital, Fushun, Liaoning, People's Republic of China.ORCID 0000-0002-3725-6929

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo report the prevalence of depression and its association with vision-related quality of life and social support in a type 2 diabetes mellitus (T2DM) population.

methodsPatients were recruited from a community-based study, Fushun Diabetic Retinopathy Cohort Study (FS-DIRECT), conducted between July 2012 and May 2013 in China. Depression was assessed using the Centre for Epidemiological Studies Depression Scale (CES-D). Vision-related quality of life was evaluated using the Visual Function Questionnaire-25 (VFQ-25). Social support was captured with the Social Support Rating Scale (SSRS). Generalized linear models were used to estimate the individual and joint association of VFQ-25 composite score (VFQCS) and SSRS score (SSRSS) with depression.

resultsA total of 1618 subjects (60.9% female) aged 61.69 ± 8.72 years in an urban district of Jiangjun Street, Fushun City, Liaoning province, Northeast China from July 2012 to May 2013 were recruited, of which, 23.36% (95% CI: 21.30-25.42%) were identified with depression. Every 14.1 increase in VFQ-25 composite score decreased the risk of depression by half (OR = 0.5; 95% CI: 0.4-0.6); with the elevation of 10.0 SSRS score the risk of depression decreased by 40% (OR = 0.6; 95% CI: 0.5-0.7). Patients with the VFQCS less than 91.3 and SSRSS less than 38.0 had 5.9 times more risk of depression (OR = 5.9; 95% CI: 3.6-9.7). Age (over 60 years) (OR = 0.6; 95% CI: 0.4-0.9) and medical history of cardiovascular disease (OR = 1.7; 95% CI: 1.1-2.5) were independently correlated with depression symptom.

conclusionThe prevalence of depression is high among patients with T2DM in urban district in northeast China. Vision-related quality of life and social support scores are significantly associated with depression. Measures should be taken to screen depressive symptoms in patients with type 2 diabetes patients. These patients need to be intervened with appropriate and effective treatment as early as possible. Meanwhile, behavioral health specialists should guide the patient to get and use social support sources effectively.

Indexed as

depressiondiabetic retinopathyquality of visionSocial Support Rating ScaleVisual Function Questionnaire-25

Identifiers

PMID35237054
PMCPMC8882658

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.